EUVIMEDEUVIMED entdecken
Open Access

DHX36 is a regulatory switch in the interferon-mediated antiviral response

Lisa Weixler iD, Daniel Hilbig, Philipp S Simon iD, Stefan Juranek iD, Julia Mahlberg iD, Martin Schlee iD, Eva Bartok iD, Markus Hafner iD, Katrin Paeschke iD

Science Advances · 29.05.2026 · 12 (22)

DOI: 10.1126/sciadv.aef5520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 29.05.2026. Verfasst von Lisa Weixler und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany. Hauptthemen laut MEDLINE: Immunity, Innate, DEAD-box RNA Helicases, Interferons, Yellow fever virus. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Innate immune and stress responses must be tightly regulated to prevent aberrant activation in the absence of pathogens. The RNA helicase DHX36 has been implicated in viral RNA sensing, but its role in immune regulation is not fully understood. Here, we show that DHX36 functions as a rheostat that restrains immune activation under homeostatic conditions while modulating antiviral signaling. Exposure to double-stranded RNA reduces DHX36 activity, enabling immune activation. In contrast, cells lacking DHX36 adopt a constitutively activated immune state characterized by accumulation of RNA G-quadruplex structures, protein kinase R (PKR)–dependent stress granule formation, and elevated interferon-stimulated gene expression. These cells also display enhanced responsiveness to the viral RNA sensor retinoic acid–inducible gene I (RIG-I) and more effectively suppress replication of a yellow fever virus replicon. Together, our findings position DHX36 as a key regulator of the type I interferon response, linking RNA structure surveillance to coordinated PKR- and RIG-I–dependent antiviral signaling and maintenance of immune homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateDEAD-box RNA HelicasesInterferonsYellow fever virusVirus DiseasesHEK293 CellsHumansClustered Regularly Interspaced Short Palindromic RepeatsGene EditingStress GranuleseIF-2 KinasePoly I-CFlavivirus InfectionsNF-kappa BSignal TransductionReceptors, ImmunologicDEAD Box Protein 58

Substanzen

DHX36 protein, humanDEAD-box RNA HelicasesInterferonsEIF2AK2 protein, humaneIF-2 KinasePoly I-CNF-kappa BRIGI protein, humanReceptors, ImmunologicDEAD Box Protein 58

Autor:innen und Institutionen

  • Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany.
  • Department of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, 53127 Bonn, Germany.
  • Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany.
  • RNA Molecular Biology Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD 20892, USA.

ORCID-Profile: Lisa Weixler, Philipp S Simon, Stefan Juranek, Julia Mahlberg, Martin Schlee, Eva Bartok, Markus Hafner, Katrin Paeschke

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Weixler, L., Hilbig, D., Simon, P. S., Juranek, S., Mahlberg, J., Schlee, M., Bartok, E., Hafner, M., & Paeschke, K. (2026). DHX36 is a regulatory switch in the interferon-mediated antiviral response. Science Advances, 12(22). https://doi.org/10.1126/sciadv.aef5520

Vancouver

Weixler L, Hilbig D, Simon PS, Juranek S, Mahlberg J, Schlee M, et al. DHX36 is a regulatory switch in the interferon-mediated antiviral response. Science Advances. 2026;12(22). doi:10.1126/sciadv.aef5520

BibTeX
@article{Weixler2026,
  author = {Weixler, Lisa and Hilbig, Daniel and Simon, Philipp S and Juranek, Stefan and Mahlberg, Julia and Schlee, Martin and Bartok, Eva and Hafner, Markus and Paeschke, Katrin},
  title = {DHX36 is a regulatory switch in the interferon-mediated antiviral response},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {22},
  doi = {10.1126/sciadv.aef5520}
}
Kostenlos starten →